Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Cancer drug development Drug prices

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news stories we’re keeping an eye on - 5 days ago Merck is a new year outlier with its diabetes drug - 19 days ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 8 months ago How resurrecting extinct species might impact medicine - 10 months ago Lawmakers want to add more Chinese biotechs to defense list - 10 months ago The Senate health committee looks into its first subpoena in 40 years - about 1 year ago The biotech updates you need to read today - about 1 year ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - about 1 year ago The biotech news you missed from the weekend - about 1 year ago Novartis is building a new radioligand plant in China - about 1 year ago Johnson & Johnson bets heavy on AI-driven drug discovery - about 1 year ago Today’s biotech news roundup, in under 800 words - about 1 year ago A new algorithm unveils CRISPR ‘treasure trove’ - about 1 year ago These are the need-to-know biotech stories from this weekend - about 1 year ago The first vaccine for the increasingly prevalent chikungunya virus is here - about 1 year ago XBI biotech index rises, giving investors a shred of hope - about 1 year ago Want a biotech buyout? Target cancer - over 1 year ago
2	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More - 14 days ago AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots - about 1 month ago
3	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	East Asians under-represented in biopharma leadership - 14 days ago Can an epilepsy drug do more than reduce seizures? - 15 days ago STAT+: 3 trends to watch in biotech in 2025 - 27 days ago A key decision on compounding is expected this week - about 1 month ago
4	Jessica Rendall CNET Journalist/Presenter @abcdarwin. Brisbane JournalismBroadcasting	Tech and Wellness Will Combine Like Never Before in 2025, but Will We Benefit? - 17 days ago
5	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	STAT stories you might have missed in 2024 - 26 days ago STAT+: Biotech analyst Brian Skorney and CEO Daphne Zohar weigh in on election results - 2 months ago
6	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - about 1 month ago A biotech’s binary bet ends badly - 7 months ago STAT+: Weed for weight loss, and more from Biotech Land - 10 months ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Milk-based therapies could be coming. This biotech CEO is aiming to lead the way. - about 2 months ago Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 5 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 5 months ago The hunt for the brain’s biomarkers - 7 months ago 4 offbeat biotechs making a splash in the life sciences - 9 months ago These biotech hotspots are ripe for IPOs - 10 months ago
8	Mario Aguilar STAT News Reporter at STATnews. Previous engagements noted. Personal views. Brooklyn techhealth care	The GLP-1 telehealth boom, Senate investigation of MA plans, and the fall of a cancer startup - 3 months ago STAT+: AI leads the way as health tech funding inches toward a post-pandemic stability - 7 months ago
9	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - 4 months ago Who’s winning in biotech’s tight market? - 4 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 5 months ago PharmaVoice 100s: Entrepreneurs - about 1 year ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - 6 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - about 1 year ago STAT+: Life science investors close nearly $6 billion in new funds - about 1 year ago

Journalists covering biotech & health